Open House Procedure: Rivaroxaban (B01af01) Conclusion of non-exclusive discount contracts in accordance with Sections 130a Paragraph 8 130c Paragraph 1 SGB V for medicinal products with the active ingredient Rivaroxaban (B01AF01) within the period from January 1st, 2024 to December 31st, 2025 with the possibility of concluding a contract at any time within the framework of a so-called open House model.In the open house procedure, medicines according to the BfArM list according to Section 35 Para. 5a SGB V (children's medicines) are excluded. The AOK Rhineland-Palatinate Saarland - The health insurance company offers all interested pharmaceutical companies discount contracts with the active company without a selection decisionoff Rivaroxaban (B01AF01). The contracts are concluded as part of an open house model. The contracts offered are not exclusive; Contracts with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz Saarland - The Health Insurance Fund. In Open House model, uniform conditions apply to all participants. Contract contents, conditions and access procedures are uniform - individual negotiations are not carried out. The contract terms are a maximum of 24 months; the earliest contract start date is January 1st, 2024. All contracts endn no later than 24 months after the earliest day the contract begins, regardless of the date on which the respective contract was concluded. Joining or concluding a contract can take place on the first of each month within the 24-month period. There is a right of termination every four weeks... AOK RHINELAND-PALATINATE SAARLAND - THE HEALTH INSURANCE FUND Address : Virchowstrasse 30 Town : Eisenberg NUTS-Code : DEB - Rheinland-Pfalz Postal Code : 67304 Phone : 49 6351403591en am_vertraege@rps.aok.de Tender Notice International Competitive Bidding 704118-2023 Germany GT-92437875

Germany